Published by Table Of Contents
Updates & Latest News
- May 12, 2026 — The FDA published Pharmacal’s nationwide recall of one lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream, 6 oz tube, after the product was found to be contaminated with Staphylococcus aureus. The affected product is lot 1024088, expiration date November 2026, product code 5106, and UPC 012277051067 [1].
What Is the Risk?
A. What Is It
The recall involves MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream sold in 6 oz tubes. The product is a topical cream used on the skin, including skin affected by eczema, irritation, or rash.
The recalled product can be identified by the following information:
- Brand: MG217
- Product: Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream
- Size: 6 oz tube
- Product Code: 5106
- UPC: 012277051067
- Lot Number: 1024088
- Expiration Date: November 2026
B. How Exposure Happens
Exposure may occur when a consumer applies the recalled cream to the skin. Pharmacal stated that the lot number can be found on the crimped end of the tube.
The recalled MG217 cream was distributed nationwide through wholesale, retail, and internet distributors, including H-E-B Grocery and Amazon. Consumers with recalled product were instructed to stop using it and discard it.
C. Health Effects
Staphylococcus aureus can cause infections ranging from localized skin infections to severe or life-threatening complications. The FDA notice warned that patients with weakened immune systems or compromised skin, including wounds, burns, or skin disorders, may face increased risk.
Potential complications may include skin and skin structure infections, infective endocarditis, bone and joint infections, bloodstream infections, sepsis, and septic shock. Consumers who experienced problems that may be related to using the recalled cream were advised to contact a physician or healthcare provider.
D. Who Is Liable
- Manufacturers involved in producing or packaging the recalled cream
- Quality control entities responsible for product safety testing
- Distributors or retailers, where legally applicable
- Other supply-chain parties connected to the recalled product, if supported by the facts
Do I Qualify?
- Did you purchase MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream?
- Does the tube show lot number 1024088 or expiration date November 2026?
- Did you or a family member use the recalled cream?
- Did anyone develop a skin infection, worsening irritation, fever, or other symptoms after use?
- Did the condition require medical care, antibiotics, hospitalization, or missed work?
- Do you still have the tube, receipt, Amazon order record, photos, or medical records?
If you answered YES to 2 or more questions, you may have a valid claim.
Notable Recalls & Legal Actions
| Product / Substance | Year | Action Type | Status | Notes |
|---|---|---|---|---|
| MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream | 2026 | Recall | Active | Lot 1024088, expiration November 2026, contaminated with Staphylococcus aureus |
Results vary. Past outcomes do not guarantee future results.
Legal Process
| Step | What Happens | Timeframe |
|---|---|---|
| 1. Consultation | An attorney reviews the recalled product, exposure history, symptoms, and available proof. | Same day – 1 week |
| 2. Investigation | Packaging, receipts, online order records, photos, and medical records are gathered. | 4–12 weeks |
| 3. File Claim | A claim or lawsuit may be filed if the facts support liability and damages. | 1–3 months |
| 4. Discovery | The parties exchange evidence about manufacturing, contamination, testing, and injuries. | 6–18 months |
| 5. Resolution | Many cases settle, though some continue toward trial. | 1–3 years total |
Frequently Asked Questions
What MG217 cream was recalled?
The recall involved MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream in 6 oz tubes, lot 1024088, with an expiration date of November 2026.
Why was the cream recalled?
The product was recalled because it was found to be contaminated with Staphylococcus aureus.
Were any adverse events reported?
No adverse events had been reported to Pharmacal at the time of the recall announcement.
What evidence should I keep?
Helpful evidence may include the cream tube, lot number, expiration date, receipt, Amazon order record, product photos, medical records, prescriptions, and any lab test results.
References
- https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pharmacal-issues-nationwide-recall-mg217-multi-symptom-treatment-cream-skin-protectant-eczema-cream
- https://www.cdc.gov/staph/about/index.html
- https://medlineplus.gov/staphylococcalinfections.html